Polyphyllin VII as a potential medication for targeting epithelial mesenchymal transitionin in thyroid cancer.

J Pharmacol Sci

Biomedical Research Institute, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Renmin Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Shiyan City, Hubei Province, PR China. Electronic address:

Published: October 2024

The need for novel anti-thyroid cancer (TC) medications is urgent due to the rising incidence and metastatic rates of malignant TC. In this study, we investigated the effect of Polyphyllin VII (PPVII) to TC cells, and explored their potential mechanism. B-CPAP and TPC-1 cells, were used to analyze the antitumor activity of PPVII by quantifying cell growth and metastasis as well as to study the effect on epithelial mesenchymal transition (EMT). The results showed that PPVII dramatically reduced the capacity of B-CPAP and TPC-1 cells to proliferate and migrate in a dose-response manner. Following PPVII treatment of TC cells, the expression levels of E-cadherin progressively increased and were higher than the control group, while the expression levels of EMT-related genes Vimentin, N-cadherin, Slug, Zeb-1, and Foxe1 gradually declined and were lower than the control group. It was proposed that PPVII might prevent TC from undergoing EMT. The Foxe1 gene was shown to be significantly expressed in TC, and a statistically significant variation in Foxe1 expression was observed across clinical stages of the disease, according to a bioinformatics database study. There was a strong link between the expression of the Foxe1 gene and the EMT-related gene. In the meantime, TC cells' expression of Foxe1 can be inhibited by PPVII. In conclusion, our results showed that PPVII may as a potential medication for targeting EMT in thyroid cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jphs.2024.07.002DOI Listing

Publication Analysis

Top Keywords

polyphyllin vii
8
potential medication
8
medication targeting
8
epithelial mesenchymal
8
thyroid cancer
8
b-cpap tpc-1 cells
8
expression levels
8
control group
8
foxe1 gene
8
expression foxe1
8

Similar Publications

Article Synopsis
  • Endometrial carcinoma (EC) often resists hormone therapies like medroxyprogesterone acetate (MPA), necessitating new treatment approaches.
  • This study examines how polyphyllin VII (PPVII) can improve MPA effectiveness by regulating microRNA (miR)-33a-5p in an MPA-resistant Ishikawa cell line.
  • Results showed that combining PPVII with MPA significantly reduced cell viability and increased apoptosis, while PPVII enhanced miR-33a-5p levels, suggesting a potential therapeutic strategy for overcoming hormone resistance in EC.
View Article and Find Full Text PDF
Article Synopsis
  • Dysregulation of Th17 and Treg cells is linked to brain damage during cerebral ischemia, suggesting that balancing these cell types could aid in post-stroke treatment.
  • Polyphyllin VII (PVII), a compound from the Rhizoma Paridis herb, shows promise in reducing brain damage and improving recovery in a mouse model of stroke by promoting Treg cells and reducing Th1/Th17 cells.
  • PVII operates by inhibiting mTORC1, affecting T cell metabolism and polarization, ultimately leading to a protective effect against cerebral ischemia-reperfusion injury.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer is caused by uncontrolled cell growth, leading to spreading in the body, and traditional Chinese medicine has introduced new treatment methods.
  • A Chinese herbal medicine referred to as RPS has documented anti-cancer effects, showing its potential to combat cancer through various mechanisms such as inhibiting tumor growth and promoting cell death.
  • The review highlights key compounds like polyphyllins that exhibit strong anti-cancer properties, aiming to provide insights for future research and applications in cancer therapies.
View Article and Find Full Text PDF

Study on Synthesis and Regulation of PPVI and PPVII in with UV.

Metabolites

August 2024

Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou 311300, China.

Article Synopsis
  • Smith var. (Franch.) Hara is a medicinal plant with beneficial components called parissaponins, known for their anti-inflammatory and anti-tumor effects, prompting research on enhancing these compounds through UV treatments.
  • * In a study, UV treatments (UVA, UVB, UVC) resulted in a significant increase in PolyPhyllin VII (PPVII) content by 32.43% with UVC after 4 hours, while other treatments decreased relevant saponin levels.
  • * The study found that UV exposure activated several enzymes involved in saponin synthesis and affected various physiological parameters, providing insights into using UV light for improving medicinal properties in plants, which is valuable for future production techniques.*
View Article and Find Full Text PDF

Polyphyllin VII as a potential medication for targeting epithelial mesenchymal transitionin in thyroid cancer.

J Pharmacol Sci

October 2024

Biomedical Research Institute, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Renmin Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Shiyan City, Hubei Province, PR China. Electronic address:

The need for novel anti-thyroid cancer (TC) medications is urgent due to the rising incidence and metastatic rates of malignant TC. In this study, we investigated the effect of Polyphyllin VII (PPVII) to TC cells, and explored their potential mechanism. B-CPAP and TPC-1 cells, were used to analyze the antitumor activity of PPVII by quantifying cell growth and metastasis as well as to study the effect on epithelial mesenchymal transition (EMT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!